Hoth Therapeutics, Inc. Gains 81.4%
Hoth Therapeutics, Inc. (HOTH:NASDAQ) jumped higher at $1.26, a gain of 81.4%. On Thu, Sep 05, 2024, HOTH:NASDAQ hit a New 2-Week High of $1.26. The stock appeared on our News Catalysts scanner on Thu, Sep 05, 2024 at 12:20 PM in the 'BIOTECH' category. From Thu, Aug 22, 2024, the stock recorded 44.44% Up Days and 50.00% Green Days
The stock spiked on Tue, Mar 19, 2024 at $1.67 with a volume of 19M+.
About Hoth Therapeutics, Inc. (HOTH:NASDAQ)
Hoth Therapeutics Inc is a development stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
Top 10 Gainers:
- ARCA biopharma, Inc. (ABIO:NASDAQ), 1052%
- Eastside Distilling, Inc. (EAST:NASDAQ), 89.22%
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 81.4%
- Altisource Asset Management Corporation (AAMC:NYSEMKT), 65.18%
- Inspire Veterinary Partners Inc. (IVP:NASDAQ), 62.95%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 60%
- BOQI International Medical Inc. (BIMI:NASDAQ), 50%
- SRM Entertainment Inc. (SRM:NASDAQ), 40.33%
- Tenon Medical Inc. (TNON:NASDAQ), 37.49%
- Ryde Group Ltd. Class A (RYDE:NYSEMKT), 33.85%